Home Other Building Blocks 1,3,5-Trioxane

1,3,5-Trioxane

CAS No.:
110-88-3
Catalog Number:
AG0035MC
Molecular Formula:
C3H6O3
Molecular Weight:
90.0779
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
95%
In Stock USA
United States
$13
- +
25g
95%
In Stock USA
United States
$19
- +
100g
95%
In Stock USA
United States
$50
- +
500g
95%
In Stock USA
United States
$172
- +
Product Description
Catalog Number:
AG0035MC
Chemical Name:
1,3,5-Trioxane
CAS Number:
110-88-3
Molecular Formula:
C3H6O3
Molecular Weight:
90.0779
MDL Number:
MFCD00006563
IUPAC Name:
1,3,5-trioxane
InChI:
InChI=1S/C3H6O3/c1-4-2-6-3-5-1/h1-3H2
InChI Key:
BGJSXRVXTHVRSN-UHFFFAOYSA-N
SMILES:
O1COCOC1
EC Number:
203-812-5
UNII:
46BNU65YNY
NSC Number:
26347
Properties
Complexity:
21.5  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
90.032g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
90.078g/mol
Monoisotopic Mass:
90.032g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
27.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  
Literature
Title Journal
Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose. Journal of medicinal chemistry 20120913
Transferable potentials for phase equilibria-united atom description of five- and six-membered cyclic alkanes and ethers. The journal of physical chemistry. B 20120913
Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97/78, a novel trioxane antimalarial compound, in rats. Arzneimittel-Forschung 20120601
1,2-Bis[(3,6,9-trimethyl-3,12-ep-oxy-3,4,5,5a,6,7,8,8a,9,10,12,12a-dodeca-hydro-pyrano[4,3-j][1,2]benzodioxepin-4-yl)-oxy]ethane. Acta crystallographica. Section E, Structure reports online 20120301
Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni. PLoS neglected tropical diseases 20120201
Formaldehyde encapsulated in lithium-decorated metal-organic frameworks: a density functional theory study. Chemphyschem : a European journal of chemical physics and physical chemistry 20120116
Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity. International immunopharmacology 20120101
Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. Journal of biomedicine & biotechnology 20120101
Synthetic peroxides as potent antimalarials. News and views. Current topics in medicinal chemistry 20120101
Profiling of volatile impurities in tetramethylenedisulfotetramine (TETS) for synthetic-route determination. Forensic science international 20110715
A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice. Bioorganic & medicinal chemistry letters 20110501
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors. Virology journal 20110101
Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS/MS method for quantification. Arzneimittel-Forschung 20110101
Conformationally constrained histidines in the design of peptidomimetics: strategies for the χ-space control. International journal of molecular sciences 20110101
Medicinal chemistry perspectives of trioxanes and tetraoxanes. Current medicinal chemistry 20110101
Liquid chromatographic tandem mass spectrometric assay for simultaneous quantification of compound 97/78 and its in vivo metabolite 97/63, a novel trioxane antimalarial, in human plasma and its application to a protein binding study. Arzneimittel-Forschung 20110101
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. PloS one 20110101
Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model. Arzneimittel-Forschung 20110101
A greatly under-appreciated fundamental principle of physical organic chemistry. International journal of molecular sciences 20110101
Trioxaquines: hybrid molecules for the treatment of malaria. Drug news & perspectives 20101201
Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes. Journal of medicinal chemistry 20101111
A suitable preparation of N-sulfonyl-1,2,3,4-tetrahydroisoquinolines and their ring homologs with a reusable Preyssler heteropolyacid as catalyst. Molecular diversity 20101101
Interspecies comparison of the pharmacokinetics and oral bioavailability of 99-357, a potent synthetic trioxane antimalarial compound. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101009
Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. The Journal of biological chemistry 20100820
Chain branching and termination in the low-temperature combustion of n-alkanes: 2-pentyl radical + O2, isomerization and association of the second O2. The journal of physical chemistry. A 20100729
(1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxy-per-hydropyrano[4,3-j][1,2]benzodiox-epine. Acta crystallographica. Section E, Structure reports online 20100701
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii. Journal of medicinal chemistry 20100513
Formaldehyde in the indoor environment. Chemical reviews 20100414
Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers. PloS one 20100101
The pharmaceutical death-ride of dihydroartemisinin. Malaria journal 20100101
Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose. Journal of medicinal chemistry 20091210
Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. Chemistry and physics of lipids 20090801
Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: a promising trioxane antimalarial in monkey plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090715
Antimalarial peroxide dyads from natural artemisinin and hydroxyalkylated 1,2,4-trioxanes. Journal of medicinal chemistry 20090528
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. Journal of medicinal chemistry 20090226
Diastereoselective preparation of substituted delta-valerolactones. synthesis of (3R,4S)- and (3R,4R)-simplactones. The Journal of organic chemistry 20090206
Ferrocenium salts mediate para-tert-butylcalixarene synthesis. Chemical communications (Cambridge, England) 20081130
New strategy for the construction of epoxy-bridged tetrahydropyran frameworks from trioxane precursors: application to a concise synthesis of a Riesling acetal. The Journal of organic chemistry 20081107
Piperidine dispiro-1,2,4-trioxane analogues. Bioorganic & medicinal chemistry letters 20081101
Accretion reactions of octanal catalyzed by sulfuric acid: product identification, reaction pathways, and atmospheric implications. Environmental science & technology 20081001
Elucidation of the natural artemisinin decomposition route upon iron interaction: a fine electronic redistribution promotes reactivity. Physical chemistry chemical physics : PCCP 20080901
1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecanes: novel spirofused bis-trioxane peroxides. Molecules (Basel, Switzerland) 20080819
Redetermination of 2,4,6-tricyclo-hexyl-1,3,5-trioxane. Acta crystallographica. Section E, Structure reports online 20080701
Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles. Journal of medicinal chemistry 20080410
A sensitive and selective liquid chromatographic tandem mass spectrometric assay for simultaneous quantification of novel trioxane antimalarials in different biomatrices using sample-pooling approach for high throughput pharmacokinetic studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080315
Malaria-infected mice are cured by oral administration of new artemisinin derivatives. Journal of medicinal chemistry 20080227
Hybrid molecules with a dual mode of action: dream or reality? Accounts of chemical research 20080101
Photoinduced oxygen capture on immobilized dienone systems. First solid-phase synthesis of trioxane scaffolds. Journal of combinatorial chemistry 20080101
Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys. Life sciences 20071110
Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1. Organic letters 20071011
Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. Journal of medicinal chemistry 20070517
New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria. Journal of medicinal chemistry 20070208
Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PloS one 20070101
Ensuring sustained ACT production and reliable artemisinin supply. Malaria journal 20070101
[Synthesis and antiviral activity of lupane triterpenoids with modified cycle E]. Bioorganicheskaia khimiia 20070101
Reactions of artemisinin and arteether with acid: implications for stability and mode of antimalarial action. Journal of medicinal chemistry 20061005
Quantitative NMR spectroscopy of complex technical mixtures using a virtual reference: chemical equilibria and reaction kinetics of formaldehyde-water-1,3,5-trioxane. Analytical and bioanalytical chemistry 20060701
8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria. Bioorganic & medicinal chemistry letters 20060201
Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins. Chembiochem : a European journal of chemical biology 20051101
New orally active spiro 1,2,4-trioxanes with high antimalarial potency. Bioorganic & medicinal chemistry letters 20051015
Conformational pathways of saturated six-membered rings. A static and dynamical density functional study. The journal of physical chemistry. A 20050915
A high throughput approach for simultaneous estimation of multiple synthetic trioxane derivatives using sample pooling for pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis 20050207
Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities. Bioorganic & medicinal chemistry letters 20050201
Synthesis and antimalarial activity of 6-cycloalkylvinyl substituted 1,2,4-trioxanes. Bioorganic & medicinal chemistry 20041115
HPLC-UV method for assaying 99/357, a synthetic trioxane antimalarial derivative in rat and rabbit serum. Journal of pharmaceutical and biomedical analysis 20041029
Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore. Organic letters 20040902
Synthesis and antimalarial activity of trioxaquine derivatives. Chemistry (Weinheim an der Bergstrasse, Germany) 20040402
Protein binding and alpha : beta anomer ratio of dihydroartemisinin in vivo. British journal of clinical pharmacology 20040401
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin. Journal of medicinal chemistry 20040226
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. Journal of medicinal chemistry 20040226
Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs. Acta tropica 20040201
Alkylation of manganese(II) tetraphenylporphyrin by a synthetic antimalarial trioxane. Organic & biomolecular chemistry 20030821
Chloroquine and artemisinin: six decades of research--what next? IDrugs : the investigational drugs journal 20030701
Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds. International journal for parasitology 20021204
Malaria: new chemotherapeutic peroxide drugs. Mini reviews in medicinal chemistry 20021201
Orally active, water-soluble antimalarial 3-aryltrioxanes: short synthesis and preclinical efficacy testing in rodents. Journal of medicinal chemistry 20020829
From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Accounts of chemical research 20020301
Biodegradation of formaldehyde and its derivatives in industrial wastewater with methylotrophic yeast Hansenula polymorpha and with the yeast-bioaugmented activated sludge. Biodegradation 20020101
Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efficacy/toxicity testing in rodents. Journal of medicinal chemistry 20010913
Quantitative (13)C NMR analysis of lignins with internal standards. Journal of agricultural and food chemistry 20010801
Properties